Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers

INTRODUCTION: Natalizumab (NTZ) discontinuation can be followed by multiple sclerosis (MS) disease reactivation. Currently no disease-modifying drug (DMD) has been shown to be able to abolish disease reactivation. The aims of the current study were: (1) to determine the frequency of MS reactivation...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurol Ther
Main Authors: Lo Re, Marianna, Capobianco, Marco, Ragonese, Paolo, Realmuto, Sabrina, Malucchi, Simona, Berchialla, Paola, Salemi, Giuseppe, Bertolotto, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4685862/
https://ncbi.nlm.nih.gov/pubmed/26647006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-015-0038-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados